Fig. 1 | Scientific Reports

Fig. 1

From: Prognostic impact of extracellular volume fraction derived from equilibrium contrast-enhanced CT in HCC patients receiving immune checkpoint inhibitors

Fig. 1

ECV fraction position of a 79 years old male with hepatocellular carcinoma receiving immune checkpoint inhibitors. Axial unenhanced (A) and equilibration contrast-enhanced CT (B) show ROIs on the 4.5 centimeters tumor (black circle) and aorta (black dashed circle). Axial unenhanced (C) and equilibration contrast-enhanced CT (D) show ROIs on the anterior and posterior segments of the right lobe and lateral segment of the left lobe of the liver (white circle) and the aorta (white dashed circle). The tumor ECV fraction was 38.48%, liver ECV fraction was 28.07%.

Back to article page